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Disruption of the suprachiasmatic 
nucleus in Fibroblast growth Factor 
signaling-Deficient Mice
Ann V. Miller* , Scott I. Kavanaugh and Pei-San Tsai
Department of Integrative Physiology, University of Colorado Boulder, Boulder, CO, USA
Fibroblast growth factor (Fgf) 8 is essential for the development of multiple brain regions. 
Previous studies from our laboratory showed that reduced Fgf8 signaling led to the devel-
opmental alterations of neuroendocrine nuclei that originated within the diencephalon, 
including the paraventricular (PVN) and supraoptic (SON) nuclei. To further understand 
the role of Fgf8 in the development of other hypothalamic nuclei, we examined if Fgf8 
and its cognate receptor, Fgfr1, also impact the integrity of the suprachiasmatic nuclei 
(SCN). The SCN control an organism’s circadian rhythm and contain vasoactive intestinal 
peptide (VIP)-producing neurons as the main input neurons. Mice hypomorphic for Fgf8, 
Fgfr1, or both were examined for their SCN volume and the number of VIP neurons on 
postnatal day (PN) 0; adult hypomorphic mice were further examined for SCN function 
by quantifying SCN neuronal activation using cFos as a marker. On PN0, mice homo-
zygous for Fgf8 hypomorphy displayed the most severe reduction of the SCN volume 
and VIP neurons. Those heterozygous for Fgf8 hypomorphy alone or Fgf8 combined 
with Fgfr1 hypomorphy, called double heterozygotes (DH), showed normal SCN volume 
but significantly reduced VIP neurons, albeit less severely than the homozygotes. Adult 
wild type, heterozygous Fgf8 hypomorphs (F8 Het), and DH mice were also examined 
for SCN cFos activation at three time points: 1 h (morning), 6 h (afternoon), and 11 h 
(evening) after light onset. In F8 Het mice, a significant change in the pattern of cFos 
immunostaining that may reflect delayed morning SCN activation was observed. Overall, 
our studies provide evidence supporting that deficiencies in Fgf8 not only impact the 
structural integrity of the SCN but also the pattern of SCN activation in response to light.
Keywords: scn, Fgf8, Fgfr1, development, cFos, ViP
inTrODUcTiOn
In early development, the ventral diencephalon undergoes significant differentiation to form the 
neuroendocrine hypothalamus. The hypothalamus controls crucial biological functions such 
as metabolism, growth, stress, reproduction, and many more. The fibroblast growth factor (Fgf) 
signaling family consists of 22 ligands and 4 tyrosine kinase receptors and is known to control the 
development of the brain (1), and importantly, the hypothalamus itself (2). Fgf8, one of the Fgf 
ligands, is expressed in the anlagen of the hypothalamus by embryonic day (E) 9.5 in the developing 
mouse embryos (3), with particularly robust expression in regions surrounding the optic chiasm (4). 
Fgfr1, one of the cognate receptors of Fgf8, is also expressed in the developing mouse embryo along 
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the linings of the third ventricle where multiple hypothalamic 
neurons emerge (5). The sites of Fgf8 and Fgfr1 expression sug-
gest an important role of Fgf8 signaling through Fgfr1 in the birth 
and survival of multiple hypothalamic neuronal populations. 
Consistent with these observations, we previously demonstrated 
that disrupted Fgf8 signaling reduced hypothalamic oxytocin-
producing neurons in the paraventricular (PVN) and supraoptic 
(SON) nuclei (6).
The suprachiasmatic nuclei (SCN) of the hypothalamus 
consist of thousands of heterogeneous neurons that regulate 
endogenous circadian rhythms and are considered the master 
clock in mammals (7, 8). The paired nuclei are subdivided into 
two major regions: the ventrolateral core and the dorsomedial 
shell. The SCN receive photic stimuli from the retina via the 
retinohypothalamic tract (RHT) (9, 10). Direct innervation 
from specialized melanopsin-containing retinal ganglion cells 
also modulates the light entrainment of the SCN (11). Although 
the SCN generate endogenous circadian rhythms in the absence 
of external cues, they also respond to and entrain to exogenous 
cues such as the light/dark cycle. The SCN are resistant to reset-
ting from non-photic cues that typically cause phase-shifts in 
peripheral clocks (12–14); thus, light is the main stimulus for the 
SCN. Once the light signal reaches the SCN, it will first activate 
the main input neurons producing vasoactive intestinal peptide 
(VIP) within the SCN core (15). Consequently, VIP, a 28-amino 
acid peptide, is released to control and maintain communication 
among other regions of the SCN and to generate continual SCN 
rhythmicity (16, 17). The expression of cFos, an immediate early 
gene, in the SCN neurons has been successfully used as a cellular 
marker for the photic activation of the SCN (18).
Because disrupted Fgf8 signaling reduces oxytocin-producing 
neurons in the PVN and SON (6), we hypothesize that other 
hypothalamic neuronal populations may also be markedly 
affected when Fgf signaling is impaired. We further hypothesized 
that deficiencies specifically in Fgf8 and one of its cognate recep-
tors, Fgfr1, impact the development and the integrity of the SCN. 
Using newborn and adult transgenic mice hypomorphic for Fgf8, 
Fgfr1, or both, we examine if Fgf signaling deficiencies disrupt the 
SCN development and alter the pattern of SCN activation later in 
life. Our results reveal severe developmental disruptions of the 
SCN in newborn Fgf8- and Fgfr1-deficient pups. Further, gauged 
by cFos immunostaining, Fgf8 deficiency significantly alters the 
pattern of SCN neuronal activation in adults during the light 




Mice hypomorphic for Fgf8 [(19), 129P2/OlaHsd* CD-1, 
obtained from Mouse Regional Resource Centers, Davis, CA, 
USA] or hypomorphic for Fgfr1 [(20), 129sv/CD-1, obtained 
from Canadian Mutant Mouse Repository] were kept on a 
12L:12D photoperiod and fed water and rodent chow ad libitum. 
Fgf8 and Fgfr1 hypomorphs have global reductions in functional 
transcript levels of 54 and 66–80%, respectively, due to a neo-
cassette insertion that creates false splice sites. The mice used in 
these studies were bred at the University of Colorado at Boulder 
by crossing male and female mice each hypomorphic for both 
Fgf8 and Fgfr1 alleles (called double heterozygous or DH mice). 
This cross produced offspring of seven genotypes: wild type 
(WT), Fgf8 heterozygous hypomorph (F8 Het), Fgf8 homozy-
gous hypomorph (F8 Hom), Fgfr1 heterozygous hypomorph (R1 
Het), Fgfr1 homozygous hypomorph (R1 Hom), DH, and double 
homozygous hypomorph (DHom). All homozygous animals, 
including F8 Hom, R1 Hom, and DHom, die within 24 h of birth 
and were used only for the study of postnatal day (PN) 0 animals. 
Adult WT, F8 Het, and DH mice were used to examine the neu-
ronal activation within the SCN at different time points during 
the light phase. Genotypes of the animals were determined by 
polymerase chain reaction (PCR) of genomic DNA obtained 
from tail biopsies. All animal procedures complied with protocols 
approved by the Institutional Animal Care and Use Committee at 
the University of Colorado Boulder.
activation of cFos in adult scn
Mixed-sex adult mice between PN50 and PN60 were used to 
examine the activation of cFos in the SCN. WT, F8 Het, and DH 
mice were collected at three different time points throughout 
the day: 1  h (morning), 6  h (afternoon), and 11  h (evening) 
after the onset of light. After isoflurane anesthesia, mouse brains 
were harvested and blocked at 0.50 and −2.06 mm anterior and 
posterior of bregma, respectively, immersion-fixed in 4% para-
formaldehyde at 4°C for 24 h, and cryoprotected in 30% sucrose 
until cFos immunohistochemistry (IHC).
ViP and cFos immunohistochemistry
For VIP immunostaining, brains of mixed-sex PN0 pups 
were harvested at 2  h after light onset, immersion-fixed in 4% 
paraformaldehyde at 4°C for 6 h, cryoprotected in 30% sucrose, 
coronally sectioned at 20-μm thickness using a cryostat, and 
thaw-mounted onto gelatin-coated slides. For cFos immu-
nostaining, adult brains described above were cryosectioned 
at 50-μm thickness, and floating sections were collected into 
phosphate-buffered saline (PBS). IHC for VIP was performed 
using an anti-VIP antibody [1:1000; a gift from Dr. Dick Swaab 
(21–23)], and IHC for cFos was performed using an anti-cFos 
antibody [1:400; Santa Cruz Biotechnology, Dallas, TX, USA 
(24–26)]. Sections were incubated in the primary antibody for 
1 week (for VIP IHC) or 48 h (for cFos IHC). The sections were 
then incubated sequentially with a secondary biotinylated donkey 
anti-rabbit antibody,  avidin–biotin complex (ABC; Vector Labs, 
Burlingame, CA, USA), and reacted with diaminobenzidine with 
(cFos IHC) or without (VIP IHC) 0.05% nickel enhancement for 
color detection. After the color reaction, floating sections were 
washed and mounted onto gelatin-coated slides. All slides were 
counterstained with 1% methyl green, a nuclear stain, to visualize 
the perimeters of the SCN before dehydration and coverslipping.
Quantification of scn neurons and 
Volume
The numbers of VIP- and cFos-immunoreactive (ir) neurons were 
counted by an investigator blind to the genotype of the animal. For 
VIP neuronal quantification, only SCN cells with clearly defined 
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morphology and cytosolic VIP immunostaining were scored. For 
cFos quantification, an ocular grid was used to assist with the 
scoring. Only SCN cells with clear nuclear cFos immunostaining 
were scored. Because cFos staining intensity within the SCN was 
clearly bimodal, we also classified cFos-ir neurons subjectively into 
darkly and lightly stained neurons. We validated this classification 
by analyzing the optical density of 40 randomly selected c-Fos-ir 
neurons and found that the density of lightly stained neurons 
was 58.8 ± 1% of darkly stained neurons. For most analyses, all 
sections of the SCN were scored and summed to obtain the total 
neuron numbers positive for VIP or cFos. For the comparison of 
cFos staining between the SCN core and shell, only the six most 
medial SCN sections with a clear delineation of the core and shell 
were quantified. The SCN surface area was measured by freehand 
tracing of the SCN perimeter using NIH ImageJ. The SCN area in 
each section was calibrated and multiplied by the section thickness 
to obtain the volume. SCN volumes in all sections were summed 
to obtain the total volume of the SCN for each animal.
statistical analysis
All statistical analyses were performed using Prism (GraphPad, La 
Jolla, CA, USA). PN0 data were analyzed using one-way ANOVA, 
and data from adults were analyzed by two-way ANOVA, both 
followed by Tukey’s multiple comparisons test. All data have been 
tested for normality using Bartlett’s test or Brown–Forsythe’s test. 
Differences were considered significant when p < 0.05.
resUlTs
ViP neurons and scn Volume in Pn0 
Transgenic Mice Deficient in Fgf signaling
VIP neurons within the SCN core were counted in newborn 
pups across all seven genotypes. One-way ANOVA revealed a 
significant effect of genotype on VIP neurons [F(6,24) =  52.9, 
p < 0.001]; Figure 1A. Tukey’s multiple comparisons post hoc test 
revealed that except for R1 Het, all transgenic genotypes exhibited 
significantly reduced VIP neurons compared to WT animals 
(Figure  1A). All three homozygous mice (F8 Hom, R1 Hom, 
Dhom) had very few VIP neurons within the SCN core, but the two 
transgenic mice harboring homozygous Fgf8 hypomorphy (F8 
Hom and DHom) had the greatest deleterious effect. We further 
examined if the volume of the SCN in PN0 pups was altered by 
Fgf signaling deficiency (Figure 1B). One-way ANOVA revealed 
a significant effect of genotype on SCN volume [F(6,24) = 7.662, 
p = 0.0001]. Tukey’s multiple comparisons post hoc test revealed 
that F8Hom and DHom pups exhibited severely diminished SCN 
volume; however, other transgenic genotypes were not different 
from WT (Figure 1B). Representative photomicrographs of SCN 
VIP immunostaining in PN0 mice were shown in Figure 1C.
scn Volume in adult Mice Deficient in Fgf 
signaling
Because mice harboring homozygous hypomorphy in Fgf8 and/or 
Fgfr1 die within 24 h of birth and R1 Het mice did not exhibit any 
SCN-related phenotype on PN0, only WT, F8 Het, and DH mice 
were used for further adult studies. First, we analyzed the volume of 
adult SCN to examine if any age-dependent deterioration occurred 
in transgenic mice. The measurements of the SCN volume were 
3.59 × 107 ± 2.17 × 106 μm3 for WT, 3.33 × 107 ± 2.34 × 106 μm3 
for F8 Het, and 3.44 × 107 ± 1.72 × 106 μm3 for DH. Similar to 
PN0 data (Figure 1B), one-way ANOVA revealed no significant 
difference in the SCN volume among adult WT, F8 Het, and DH 
mice [F(11,60) = 0.8863, p = 0.5569].
Total cFos activation in scn of adult  
Mice Deficient in Fgf signaling
The significant reductions of VIP neurons in PN0 F8 Het and 
DH mice (Figure 1A) suggest developmental abnormalities and 
possibly functional defects later in life. To address the latter, cFos 
IHC was performed on adult WT, F8 Het, and DH at 1, 6, and 
11 h after light onset to gauge cFos activation in the presence of 
light (Figure 2). Two-way ANOVA revealed a significant effect of 
time of day [F(2, 27) = 9.445, p = 0.0008] but not genotype [F(2, 
27) = 0.1995, p = 0.8204] on the number of SCN cFos-ir neurons. 
There was no significant genotype × time of day interaction [F(4, 
27) = 0.6366, p = 0.6408]. Interestingly, F8 Het mice exhibited 
significantly elevated afternoon activation of cFos compared to 
the morning (p < 0.05), a feature lacking in both WT and DH 
mice, suggesting altered SCN activation in these mice.
Since the intensity of cFos staining may reflect the timing 
and degree of neuronal activation, we examined both darkly 
and lightly cFos-stained neurons among genotypes and at 
different time of day. Two-way ANOVA of neurons darkly 
stained for cFos (Figure 3A) showed a significant effect of time 
of day [F(2, 27) = 11.01, p = 0.0003] but no effect of genotype 
[F(2, 27)  =  0.4640, p  =  0.6337] or genotype  ×  time of day 
interaction [F(4, 27) = 0.7137, p = 0.5898]. Specifically, the F8 
Het animals displayed a significantly higher level of neuronal 
activation in the afternoon than morning (Figure 3A). Two-way 
ANOVA for lightly stained neurons (Figure 3B) showed no sig-
nificant effect of genotype [F(2, 27) = 0.6740, p = 0.5181], time 
of day [F(4, 27) = 0.1796, p = 0.9470], or genotype × time of day 
interaction [F(4, 27) = 0.1796, p = 0.9470].
regional cFos activation in scn of adult 
Mice Deficient in Fgf signaling
We further investigated if cFos in the shell and the core of the 
SCN may be differentially activated among genotypes at different 
times of the day. In the morning, there was no effect of geno-
type or SCN subregion on cFos activation [F(2,18) =  0.09268; 
p = 0.9119, Figure 4A]. In the afternoon, although there was no 
genotype effect [F(2, 18) = 0.2176, p = 0.8065, Figure 4B], a sig-
nificant effect of SCN subregion was observed [F(1, 18) = 25.68, 
p < 0.0001], with the post hoc test revealing a significant difference 
between the core and shell activation in only F8 Het (p < 0.05). 
There was no significant genotype × SCN subregion interaction 
in the afternoon [F(2, 18) =  0.2534, p =  0.7789, Figure  4B]. 
In the evening, there was no significant genotype effect 
[F(2, 18) = 0.5814, p = 0.5693, Figure 4C], but again, a significant 
effect of subregion was observed [F(1, 18) = 26.35, p < 0.0001], 
with the post hoc test revealing a significant difference between 
the core and shell activation in only WT (p < 0.05). There was 
FigUre 2 | cFos-ir neurons in the entire SCN of PN 50–60 mice at three 
different time points: morning (1 h after the onset of light), afternoon (6 h after 
the onset of light), and evening (11 h after the onset of light). N = 4 for each 
genotype and time point. *p < 0.05.
FigUre 1 | (a) VIP-ir neuron numbers in the SCN core of PN0 mice (WT, n = 6; F8 Het, n = 5; R1 Het, n = 5; DH, n = 5; F8 Hom, n = 4; R1 Hom, n = 3; Dhom, 
n = 3). Different letters indicate significant differences (p < 0.0001). (B) Total SCN volume at PN0. Different letters indicate significant differences (p < 0.0001).  
(c) Representative photomicrographs of VIP-ir neurons in the SCN at PN0. Scale bar = 100 μm. The brown staining indicates VIP-ir neurons, and green staining is 
the methyl green nuclear counterstain.
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no significant genotype ×  subregion interaction in the evening 
[F(2, 18) = 0.1320, p = 0.8772]. Figure 4D shows representative 
photomicrographs of SCN cFos immunostaining in WT and F8 
Het mice.
DiscUssiOn
In this study, we investigated if deficiencies in several Fgf signal-
ing components impacted the structural development and adult 
function of the SCN. We demonstrated that at birth, mice with 
heterozygous deficiency in Fgf8 (alone or combined with Fgfr1) 
had fewer VIP neurons compared to WT mice. Interestingly, the 
SCN were largely absent in mice with homozygous deficiency 
in Fgf8 but not Fgfr1. Lastly, our data suggested Fgf8 deficiency 
altered the temporal pattern of SCN activation in adults. Overall, 
we have shown, for the first time, a significant role of Fgf signal-
ing, in particular Fgf8, in establishing the structure and certain 
functional aspects of the SCN neurocircuit.
Several lines of evidence from the current study suggest 
Fgf8 plays a more critical role than Fgfr1 in the SCN develop-
ment. First, in heterozygous transgenic pups, only those with 
Fgf8 hypomorphy showed disrupted VIP neurons (Figure 1A). 
Heterozygous Fgfr1 hypomorphy had no effect. Second, in 
homozygous transgenic pups, only those with Fgf8 hypomorphy 
(F8 Hom and DHom) showed severely diminished or absent 
SCN. Homozygous Fgfr1 hypomorphy had no effect on SCN 
volume (Figure 1B). The greater dependence of the SCN devel-
opment on Fgf8 could be explained by Fgf signaling redundancy 
and expression patterns. In rodents, hypothalamic nuclei are 
FigUre 3 | (a) Darkly stained and (B) lightly stained cFos-ir neuron numbers 
in the SCN of PN50-60 WT, F8 Het, and DH at three different time points: 
morning (1 h after the onset of light), afternoon (6 h after the onset of light), 
and evening (11 h after the onset of light). N = 4 for each genotype and time 
point. *p < 0.05.
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formed by the clustering of neurons born within and migrate 
from the proliferative ventricular zone of the diencephalon (2, 
27). Fgfr1, 2, and 3 are all expressed along this proliferative zone 
(28), but Fgf8 is the only ligand expressed robustly in the ventral 
diencephalon near the presumptive SCN (3, 5, 29). Fgfr1, 2, and 
3 may work collaboratively to support the genesis of multiple 
hypothalamic neuronal populations along the ventricular zone; 
thus, deficiency in only Fgfr1 may not severely impact neuro-
genesis. Once hypothalamic neurons are fate-specified and reach 
the presumptive SCN, their maturation and survival in the SCN 
may depend solely on Fgf8 since other compensatory factors 
may not be available. This could also explain why heterozygous 
defects in Fgf8 and Fgfr1 were not additive in their develop-
mental impact; the consequence of Fgf8 deficiency would be 
more deleterious and likely to mask that of Fgfr1 deficiency. 
Regardless, our results speak to the exquisite sensitivity of the 
developing SCN to Fgf8.
Although significant reductions in the SCN VIP neurons were 
observed in F8 Het and DH mice, their SCN volumes were not 
altered (Figure  1B). One interpretation was that VIP neurons 
may still be present in the SCN but were unable to produce their 
hallmark neuropeptide due to disrupted transcription, transla-
tion, or post-translational processing of the VIP prohormone. 
In support of this, we previously showed that Fgf8 deficiency 
delayed the processing of the oxyphysin prohormone in the 
PVN, leading to reduced oxytocin-ir neurons in newborn mice 
(6). Alternatively, VIP neurons may have died developmentally, 
but the loss of a few hundred neurons may not have a discernible 
impact on the total SCN volume.
We used cFos as a marker of neuronal activation (18, 30) to 
gauge the pattern of SCN neuronal activation immediately after 
light onset (morning) and then throughout the remaining light 
phase (Figure 2). Although WT mice showed consistent levels of 
cFos activation throughout the day, F8 Het exhibited a significant 
increase in cFos activation in the afternoon compared to morning 
(Figure 2). The discrepant activation pattern could be due to a 
delayed morning cFos activation in F8 Het, leading to a greater 
difference between morning and afternoon. DH mice also exhib-
ited a pattern similar to F8 Het, but a significant time difference 
was not observed.
The cFos activation in the SCN of our WT mice was consistent 
throughout different times of the day (Figure 2). Although similar 
results have been reported (31), there was considerable variability 
in the literature on the diurnal pattern of SCN cFos activation in 
rodents (32, 33). We surmise that differences in the time course 
examined and light regimen employed between the previous and 
current studies may underlie these variabilities. Regardless, the 
significant alteration in the pattern of cFos activation in F8 Het 
mice suggested Fgf8 played a role in not only the development of 
the SCN, but also its temporal pattern of activation during the 
light phase.
Our total cFos neuronal counting (Figure 2) included lightly 
stained neurons that could confound our data interpretation 
because they may represent cells weakly activated or past the 
stage of optimal activation. As such, we discriminated between 
neurons of two staining intensities: lightly stained and darkly 
stained (Figure 3). The lightly stained neurons were present at 
a much lower level than the darkly stained neurons, suggesting 
most neurons were optimally activated at the time points sampled. 
As expected, lightly stained neurons exhibited no discernible 
pattern of activation throughout the day or differences among 
genotypes (Figure  3B). Darkly stained neurons (Figure  3A), 
however, recapitulated the pattern of total neurons stained with 
cFos (Figure 2). Overall, these results confirmed that our early 
data on total cFos-positive neuronal count correctly captured the 
temporal pattern of SCN activation.
We next interrogated if the cFos activation pattern differed 
between the SCN subregions among the genotypes. The core 
neurons receive a photic signal from the RHT and relay the 
signal to the remaining SCN; thus, one would expect the shell to 
become activated later than the core (34). Previous studies have 
also shown that Per gene expression, which regulates circadian 
oscillations within the SCN, is delayed in response to a light 
pulse in the shell compared to the core (35–37). Indeed, our data 
showed that as the day progressed, the shell became generally 
more activated than the core, but the difference between the core 
and shell occurred earlier in F8 Het (Figure 4B), suggesting sev-
eral possibilities. First, the activation of the SCN core may have 
FigUre 4 | cFos-ir neurons within the SCN shell and the core in the (a) morning (1 h after the onset of light), (B) afternoon (6 h after the onset of light), or (c) evening 
(11 h after the onset of light). N = 4 for each genotype and time point. *p < 0.05. (D) Representative photomicrographs at each of the three time points for WT and 
F8 Het only. Blue dotted line outlines the core, and yellow dotted line outlines the shell.
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decreased prematurely in F8 Het, causing an earlier subregional 
difference. Second, WT mice may have relayed the signal more 
robustly to the shell, thus maintaining a higher level of activation 
later in the day. Nevertheless, these pattern differences are subtle, 
and the impact they may have on the daily activity of F8 Het mice 
remains to be explored.
In sum, our results suggest that Fgf8 plays a critical role in the 
development and some functional aspects of the SCN in adult-
hood. Since circadian rhythm governs the most fundamental 
physiological functions in vertebrates, the disruption of Fgf8 
signaling may have far-reaching impacts on the overall health of 
organisms. For example, Fgf8 deficiency may also detrimentally 
impact sleep, metabolism, reproduction, feeding, growth, and 
aging by secondarily altering the SCN organization (38–43). 
Since humans harboring Fgf8 mutations have been identified 
(44), our results shed light on potential circadian disorders yet to 
be diagnosed in these afflicted individuals.
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